Read More Pharma Industry News Windjammer Capital acquires monoclonal antibodies producer Bio X Cell Windjammer Capital Investors (“Windjammer”), a notable private equity investment firm, has announced its acquisition of Bio X Cell,… byPallavi MadhirajuDecember 13, 2023